As asparaginase is a critical component of the ALL chemotherapy protocol, it is important to be aware of asparaginase-associated toxicity and to detect it at an early stage in order to enable efficient and appropriate management and continue therapy as much as possible. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.